Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease
| Autor: | Park, Steven I., Shenoi, Jaideep, Pagel, John M., Hamlin, Don K., Wilbur, D. Scott, Orgun, Nural, Kenoyer, Aimee L., Frayo, Shani, Axtman, Amanda, Bäck, Tom, Lin, Yukang, Fisher, Darrell R., Gopal, Ajay K., Green, Damian J., Press, Oliver W. * |
|---|---|
| Zdroj: | In Blood 18 November 2010 116(20):4231-4239 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|